Phase I Study of Perifosine and Sorafenib for Patients With Advanced Cancers

An Open-Label Phase I Study of the Safety of Perifosine in Combination With Sorafenib for Patients With Advanced Cancers

Sponsor(s)

AOI Pharmaceuticals

Principal Investigator(s)Jonathan L Kaufman, MD
Dates10/01/2007 - 9/30/2010